IP Verse

Wibbelmann patent opposition analysis

Law FirmOpposition Filing Analysis

The comprehensive analysis of Wibbelmann opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Wibbelmann

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP2922532	5-Aminosalicylic Acid Capsule Formulation	WARNER CHILCOTT	Dec 5, 2019	WIBBELMANN
EP3205338	Method Of Producing Enteric Soft Capsule	FUJI CAPSULE	Sep 19, 2019	CP KELCO APS
EP3056187	Single-Dose Pharmaceutical Preparation Of Thyroid Hormones T3 And/Or T4	ALTERGON	May 17, 2019	UNI PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES
EP2510015	Inactivation Of Off-Taste Inducing Enzymes	DUPONT NUTRITION BIOSCIENCES APS	Mar 27, 2019	CP KELCO
EP2477611	(Z)-2-Cyano-3-Hydroxy-But-2-Enoic Acid-(4'-Trifluormethylphenyl)-Amide Tablet Formulations With Improved Stability	SANOFI AVENTIS DEUTSCHLAND	Dec 29, 2017	WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB
EP2346475	Personal Care Compositions Providing Enhanced Cooling Sensation	THE PROCTER & GAMBLE	Dec 15, 2017	COLGATE PALMOLIVE
EP2996777	Oral Care Compositions	UNILEVER	Dec 1, 2017	COLGATE PALMOLIVE

Top companies who are the clients of Wibbelmann

Company	Total
COLGATE PALMOLIVE	2
CP KELCO	1
CP KELCO APS	1
UNI PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES	1
WIBBELMANN	1
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB	1